🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Radiation Oncology is an alphabet soup of terminology! What does SBRT/SAbR mean? IMRT? Proton? Learn how we categorize our radiotherapy treatments in this 3 minute video clip.

Thank you so much for your support! 🙏Sakditad “Tew” Saowapa, MD Truly appreciate it and excited to continue working to advance 🌟 #HealthEquity in #NSCLC! #AACR25 #CancerResearch #NHPI

Bowel regimen, anyone? What’s the difference between different laxatives? Take a look at this great graphic to learn more ⤵️

What were the biggest lung cancer takeaways from #AACR25? 🧬 In the latest #LungCancerConsidered, Stephen V Liu, MD & Christine Lovly, MD, PhD, FASCO break down results from the Beamion LUNG-1, AENEAS, and SignPost studies. 🎧 Listen now: bit.ly/AACR25Highligh…

✨Honored to present our study at #AACR25! 📊 Disparities in #NSCLC among Native Hawaiian & Pacific Islander (#NHPI) patients reveal significant differences in stage at diagnosis, treatment, & insurance status. 🔍 Key Findings 🌺PI patients: younger, advanced stage, underinsured,

I’m learning Spanish on Duolingo! It’s free, fun, and effective.

1/2 Here’s our updated advanced urothelial cancer Uromigos Score (20 experts from around the world). It’s designed to give clinical strength/granularity to guidlines (which often give a list of equal options). Thanks to those that took part (on the 2nd slide). As things change,

Keep up the good work with my Spanish!!

Words of wisdom from my attending in clinic today: “Your worst day may be your patient’s best day; just remember that and choose to be kind always” There’s always room for kindness 😊

1/3🧵 🔥Hot off the press. ⭐️My co-authors & I are excited to share this just published paper ASCO #ASCO25 #ASCOEdBook on a topic that is near & dear to my heart: ✅“The ART of #Oncology #Education & #Knowledge Sharing. It is All About the “#How” 👇🏻 ascopubs.org/doi/10.1200/ED…

Treatment Algorithm: This is the algorithm we have use during our discussion w/ Mark Awad for mNSCLC with no actionable mutation in 1L! #OncTwitter #MedTwitter #lcsm

#ESMOBreast25 Recent Advances In Treatment For Hr+ Her2- Breast Cancer from Dr. Sara Tolaney wonderful presentation👇 #ESMOAmbassadors ESMO - Eur. Oncology

Thrilled to share that two of my abstracts have been accepted for online publication at the 2025 ASCO Annual Meeting! I’m incredibly grateful for the opportunity to contribute to the field through research on: •Breast cancer subtypes in the U.S. •Atrial fibrillation and

Treatment Algorithm: This is the algorithm we have use during our discussion w/ Susan Combs Scott, MD for mNSCLC with potential actionable mutation in 1L! #OncTwitter #MedTwitter #lcsm

Sakditad “Tew” Saowapa, MD ASCO Natchaya “Gift” Polpichai, MD 🎉 Congratulations!! Sakditad “Tew” Saowapa, MD So proud to be part of this important work with you! Your dedication and insight continue to inspire—excited to see our research on breast cancer and HCC make it to #ASCO25! 👏🔬 #Oncology #MedTwitter

(1/9) Thrilled and honored to share our NatureRevClinOncol comprehensive review dissecting the crosstalk between non-small-cell lung cancer (NSCLC) and its tumour microenvironment (TME), and how it drives progression & response to therapy. ➡️ nature.com/articles/s4157…

Two of my Abstracts have been Accepted for Online Publication at the 2025 ASCO Annual Meeting - Sakditad “Tew” Saowapa, MD ASCO oncodaily.com/url/296418 #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer #CancerWorld #ASCO2025 #ASCO25

Treatment Algorithm: This is the algorithm we have used during our discussion w/ Ticiana Batista (Leal) for Small Cell #LungCancer #OncTwitter #MedTwitter #lcsm

🔥🚨OncoAlert Hot off the press. #BigNews from ASCO NEW interactive #AI tool developed by #ASCO & @GoogleCloud: ✅The ASCO #Guidelines #Assistant Great tool to search & use ASCO Clinical Practice #Guidelines through a simple intuitive chat. 👇🏻 brnw.ch/21wSPeh

‼️The countdown begins! Just one week until the world’s biggest stage for oncology science: #ASCO25. As an upcoming heme-onc fellow, I’m diving into all 5,000 abstracts—hungry to learn, grow, and contribute. Let’s chase breakthroughs and aim to be the best in the field. ASCO